{
  "ticker": "IIQ",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967828",
  "id": "02967828",
  "pages": 1,
  "price_sensitive": false,
  "date": "20250709",
  "time": "1528",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250709/pdf/06ln124k5vrxjn.pdf",
  "summary": "**Investor Briefing Announcement:**  \n- **Event:** online Investor Briefing on **EXO-OC test** (ovarian cancer diagnostics) and **CAR-exosome therapy** (preclinical for breast/lung cancers).  \n- **Date/Time:** 14 July 2025, 3:00\u20133:30 PM AEST.  \n- **Key Focus:** Recent results for EXO-OC and in vitro CAR-exosome data.  \n- **Moderator:** MST analyst Chris Kallos (Q&A host).  \n\n*No material financial, trading, or capital markets impact identified.*",
  "usage": {
    "prompt_tokens": 764,
    "completion_tokens": 126,
    "total_tokens": 890,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-09T05:40:25.009629"
}